4//SEC Filing
SCHEINBERG DAVID A 4
Accession 0001104659-21-033301
CIK 0001390478other
Filed
Mar 7, 7:00 PM ET
Accepted
Mar 8, 4:30 PM ET
Size
14.6 KB
Accession
0001104659-21-033301
Insider Transaction Report
Form 4
SCHEINBERG DAVID A
Director
Transactions
- Award
Stock Option (Right to Buy)
2021-03-04+7,500→ 7,500 totalExercise: $8.00Exp: 2031-03-04→ Common Stock (7,500 underlying)
Footnotes (1)
- [F1]The shares subject to the option will fully vest on the earlier of (x) March 4, 2022 (the first anniversary of the date of grant) or (y) the business day prior to the 2022 annual stockholders meeting, subject to the Reporting Person's continued service on the Issuer's Board of Directors through such date.
Issuer
SELLAS Life Sciences Group, Inc.
CIK 0001390478
Entity typeother
Related Parties
1- filerCIK 0001250316
Filing Metadata
- Form type
- 4
- Filed
- Mar 7, 7:00 PM ET
- Accepted
- Mar 8, 4:30 PM ET
- Size
- 14.6 KB